Prostaglandin E augments the effect of chemotherapy on B-16 melanoma in vivo
- 1 June 1982
- journal article
- research article
- Published by Elsevier in Journal of Surgical Research
- Vol. 32 (6) , 555-562
- https://doi.org/10.1016/0022-4804(82)90139-1
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Influence of PGE on the immune response in melanoma-bearing mice.The Journal of Immunology, 1980
- The effect of PGA1 on the immune response in B-16 melanoma-bearing miceProstaglandins, 1980
- Inhibition of DNA synthesis in harding-passey melanoma cells by prostaglandins A1 and A2: Comparison with chemotherapeutic agentsBiochemical and Biophysical Research Communications, 1979
- Dopamine: A Novel Antitumor Agent Active Against B-16 Melanoma In VivoJournal of Investigative Dermatology, 1978
- Dose dependent inhibition of B-16 melanoma growth in vivo by a synthetic analogue of PGE2Prostaglandins, 1977
- Inhibition of tumour growth in vivo and in vitro by prostaglandin ENature, 1976
- Prostaglandin E (PGE) control of cell proliferation in vitro: Characteristics of HT-29Journal of Surgical Research, 1974
- The relationship between concentration of prostaglandin E and rates of cell replicationExperimental Cell Research, 1974
- Immunodeficiency And CancerAdvances in Cancer Research, 1973
- THE MODE OF ACTION OF 5-FLUOROURACIL AND ITS DERIVATIVESProceedings of the National Academy of Sciences, 1958